pentobarbital will lessen the extent or influence of isavuconazonium sulfate by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.The onset of motion for oral or rectal administration differs from 20 to sixty minutes. For IM administration, the onset of action is somewhat more quickly. Subsequent IV administration, the onset of